Cancer
(asked on 9th October 2018) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the £200 million allocated to the Cancer Transformation Funding, how much funding each Cancer Alliance (a) received in (i) 2017-2018 and (ii) 2018-2019; and (b) how much such funding remains outstanding.
NHS England is allocating £200 million transformation funding in 2017/18 and 2018/19 to support Cancer Alliances to deliver improvements in faster and earlier diagnosis and quality of life for people living with a cancer diagnosis. Over £72 million was released in 2017/18 to support Cancer Alliances to transform cancer services. A further £9 million went to Greater Manchester to support its Cancer Alliance, as part of a devolution agreement.
For 2018/19, the allocation for each Cancer Alliance is as follows:
Cancer Alliance | Total Funding (£) |
Northern | 6,991,000 |
West Yorkshire and Harrogate | 5,410,000 |
South Yorkshire | 3,445,000 |
Cheshire and Merseyside | 5,552,000 |
Lancashire and South Cumbria | 3,307,000 |
Humber, Coast and Vale | 3,764,000 |
Greater Manchester | 14,500,000 |
West Midlands | 18,103,000 |
East Midlands | 8,842,000 |
East of England | 16,094,000 |
Thames Valley | 5,369,000 |
Kent and Medway | 2,301,000 |
Surrey and Sussex | 3,128,000 |
SWAG | 5,084,000 |
Peninsula | 3,179,000 |
Wessex | 7,282,000 |
South East London | 2,764,000 |
RM Partners | 12,048,000 |
UCLH Cancer Collaborative | 11,130,000 |
Pan-London | 2,832,000 |
TOTAL | 141,125,000 |
The figures above include both the revenue and capital funding allocated to each Alliance.